A new finger prick test claims to detect Alzheimer’s with 91% accuracy using p-tau217 biomarkers. Learn how this accessible ...
The specimen of choice that enables the collection of small blood volumes from neonatal or critically ill patients is a capillary blood specimen. This specimen type has gained favour with many ...
Alzheimer’s disease biomarkers measured from finger-prick dried blood samples closely match standard plasma tests and predict CSF pathology with good accuracy, a large-scale study shows.
Babson and BD are advancing development of the blood testing ecosystem, which includes BD’s capillary-collection technology and Babson’s proprietary automated sample-handling and analytical ...
BD MiniDraw™ Capillary Blood Collection System Enables Lab-Quality Blood Testing from Less Invasive Method than Venous Collection in More Convenient Locations FRANKLIN LAKES, N.J., Dec. 7, 2023 ...
AUSTIN, Texas--(BUSINESS WIRE)--Babson Diagnostics (Babson), a transformative medical technology company, is improving the way the public receives diagnostic blood testing. According to the CDC, 70% ...
New potential for Alzheimer disease biomarker testing found in dried blood collection derived from capillary blood.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback